Skip to main content

Table 2 Numbers of trials by funding source and trial design (RCT or non-RCT)

From: How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?

Funding source

Number of trials

Proportion of RCT (%)

 

RCT

Non-RCT

Total

 

Industry

142

62

204

(59.3%)

69.6

Academic

79

43

122

(35.5%)

64.8

Government

44

11

55

(16.0%)

80.0

Foundation

28

4

32

(9.3%)

87.5

Other

37

11

48

(14.0%)

77.1

Total

243

101

344

(100%)

70.6

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us